Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1 von Liang, Zhongxing, Wu, Hui, Xia, James, Li, Yuhua, Zhang, Yawei, Huang, Ke, Wagar, Nicholas, Yoon, Younghyoun, Cho, Heidi T., Scala, Stefania, Shim, Hyunsuk

Volltext

Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis von Shu, Hui-Kuo G, Yoon, Younghyoun, Hong, Samuel, Xu, Kaiming, Gao, Huiying, Hao, Chunhai, Torres-Gonzalez, Edilson, Nayra, Cardenes, Rojas, Mauricio, Shim, Hyunsuk

Volltext

Silencing of CXCR4 blocks breast cancer metastasis von ZHONGXING LIANG, YOUNGHYOUN YOON, VOTAW, John, GOODMAN, Mark M, WILLIAMS, Larry, SHIM, Hyunsuk

Volltext

Development of a unique small molecule modulator of CXCR4 von Liang, Zhongxing, Zhan, Weiqiang, Zhu, Aizhi, Yoon, Younghyoun, Lin, Songbai, Sasaki, Maiko, Klapproth, Jan-Michael A, Yang, Hua, Grossniklaus, Hans E, Xu, Jianguo, Rojas, Mauricio, Voll, Ronald J, Goodman, Mark M, Arrendale, Richard F, Liu, Jin, Yun, C Chris, Snyder, James P, Liotta, Dennis C, Shim, Hyunsuk

Volltext

CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models von YOON, Younghyoun, ZHONGXING LIANG, XIN ZHANG, CHOE, Mison, AIZHI ZHU, CHO, Heidi T, SHIN, Dong M, GOODMAN, Mark M, ZHUO CHEN, SHIM, Hyunsuk

Volltext

Early prediction of response to Vorinostat in an orthotopic rat glioma model von Wei, Li, Hong, Samuel, Yoon, Younghyoun, Hwang, Scott N., Park, Jaekeun C., Zhang, Zhaobin, Olson, Jeffrey J., Hu, Xiaoping P., Shim, Hyunsuk

Volltext

Corrigendum to “Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors” [Eur. J. Med. Chem. 181 (2019) 111562] von Gaines, Theresa, Garcia, Francisco, Virani, Saniya, Liang, Zhongxing, Yoon, Younghyoun, Oum, Yoon Hyeun, Shim, Hyunsuk, Mooring, Suazette Reid

Volltext

Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis von Wu, Rui, Yu, Wenyan, Yao, Chuansheng, Liang, Zhongxing, Yoon, Younghyoun, Xie, Yuanyuan, Shim, Hyunsuk, Bai, Renren

Volltext

Discovery of novel aminopiperidinyl amide CXCR4 modulators through virtual screening and rational drug design von Oum, Yoon Hyeun, Kell, Steven A., Yoon, Younghyoun, Liang, Zhongxing, Burger, Pieter, Shim, Hyunsuk

Volltext

Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors von Gaines, Theresa, Garcia, Francisco, Virani, Saniya, Liang, Zhongxing, Yoon, Younghyoun, Oum, Yoon Hyeun, Shim, Hyunsuk, Mooring, Suazette Reid

Volltext

Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study von Bai, Renren, Liang, Zhongxing, Yoon, Younghyoun, Salgado, Eric, Feng, Amber, Gurbani, Saumya, Shim, Hyunsuk

Volltext

Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors von Gaines, Theresa, Camp, Davita, Bai, Renren, Liang, Zhongxing, Yoon, Younghyoun, Shim, Hyunsuk, Mooring, Suazette Reid

Volltext

Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists von Virani, Saniya, Liang, Zhongxing, Yoon, Younghyoun, Shim, Hyunsuk, Mooring, Suazette R.

Volltext

A benzenesulfonamide derivative as a novel PET radioligand for CXCR4 von Oum, Yoon Hyeun, Shetty, Dinesh, Yoon, Younghyoun, Liang, Zhongxing, Voll, Ronald J., Goodman, Mark M., Shim, Hyunsuk

Volltext

Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives von Bai, Renren, Sun, Jian, Liang, Zhongxing, Yoon, Younghyoun, Salgado, Eric, Feng, Amber, Oum, Yoonhyeun, Xie, Yuanyuan, Shim, Hyunsuk

Volltext

Development of CXCR4 modulators based on the lead compound RB-108 von Bai, Renren, Jie, Xiaokang, Sun, Jian, Liang, Zhongxing, Yoon, Younghyoun, Feng, Amber, Oum, Yoonhyeun, Yu, Wenyan, Wu, Rui, Sun, Bin, Salgado, Eric, Xie, Yuanyuan, Shim, Hyunsuk

Volltext

Symmetrical bis-tertiary amines as novel CXCR4 inhibitors von Bai, Renren, Liang, Zhongxing, Yoon, Younghyoun, Liu, Shuangping, Gaines, Theresa, Oum, Yoonhyeun, Shi, Qi, Mooring, Suazette Reid, Shim, Hyunsuk

Volltext

Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties von Olivera, Anlys, Moore, Terry W., Hu, Fang, Brown, Andrew P., Sun, Aiming, Liotta, Dennis C., Snyder, James P., Yoon, Younghyoun, Shim, Hyunsuk, Marcus, Adam I., Miller, Andrew H., Pace, Thaddeus W.W.

Volltext

Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library von Bai, Renren, Shi, Qi, Liang, Zhongxing, Yoon, Younghyoun, Han, Yiran, Feng, Amber, Liu, Shuangping, Oum, Yoonhyeun, Yun, C. Chris, Shim, Hyunsuk

Volltext

Bisamide CXCR4 Modulators: Novel Anti‐IBD Agents Acting on the Chemotaxis of Inflammatory Cells von Bai, Renren, Jiang, Xiaoying, Hui, Zi, Yoon, Younghyoun, Ge, Jiamin, Zhu, Junlong, Shim, Hyunsuk

Volltext